❭

COVID-19 and reactions in the Norwegian population

The aims are to study a representative sample of Norwegian people, their quality of life, stress and coping strategies during the first phase of the corona outbreak in Norway. 

Project leader:

Tine Kristin Grimholt


Links:

Til nettskjema:
Covid-19 og reaksjoner i den norske befolkningen

 
Scroll to top

Home Covid-19 studies

  • Project summary
  • Projects at Oslo University Hospital
  • Multicenter studies (external sponsor)
  • Publications
  • COVID-19 general biobank
  • National overview of covid-19 studies
  • OUS Research Home Page www.ous-research.no

Recent publications

Publications 2026

Bergstad Larsen V, Gunnes N, Gran JM, Dahl J, Bøås H, Viksmoen Watle S, Berild JD, Greve-Isdahl M, Størdal K, Løvdal Gulseth H, Karlstad Ø, Lopez-Doriga Ruiz P, Tapia G (2026)
Adverse events following SARS-CoV-2 mRNA vaccination in norwegian adolescents
Sci Rep, 16 (1)
DOI 10.1038/s41598-026-45261-2, PubMed 41896268

Robertson AH, Wolf AS, Fossum E, Solum G, Bhandari S, Vikse EL, Kjønstad IF, Magnus P, Nygaard UC, Lund-Johansen F, Trogstad L, Mjaaland S (2026)
Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infections
Vaccine, 80, 128511 (in press)
DOI 10.1016/j.vaccine.2026.128511, PubMed 41895154

Rasmussen TH, Schikora-Rustad S, Lorentzen ÅR, Tran TT, Øverås MH, Myhr KM, Wergeland S, Aarseth J, Bø L, Berge T, Høgestøl EA, Harbo HF, Tveter AT, Jørgensen KK, Cunen C, Torkildsen Ø, Holmøy T, Celius EG, Vaage JT, Nygaard GO, Lund-Johansen F, König M (2026)
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study
BMJ Neurol Open, 8 (1), e001556
DOI 10.1136/bmjno-2026-001556, PubMed 41835014

More